Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival J. Hunter Mehaffey, MD, Lily E. Johnston, MD, MPH, Robert B. Hawkins, MD, Eric J. Charles, MD, Leora Yarboro, MD, John A. Kern, MD, Gorav Ailawadi, MD, Irving L. Kron, MD, Ravi K. Ghanta, MD The Annals of Thoracic Surgery Volume 104, Issue 1, Pages 36-41 (July 2017) DOI: 10.1016/j.athoracsur.2017.02.057 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Hemodynamic response (mean arterial pressure, cardiac index, and systemic vascular resistance) after methylene blue administration. Graphs are means and 95% confidence intervals. The Annals of Thoracic Surgery 2017 104, 36-41DOI: (10.1016/j.athoracsur.2017.02.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Vasopressor requirements (epinephrine and norepinephrine) after methylene blue administration. Graphs are means and 95% confidence intervals. The Annals of Thoracic Surgery 2017 104, 36-41DOI: (10.1016/j.athoracsur.2017.02.057) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions